| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $102.48M | $62.04M | $153.73M | $67.77M | $61.88M |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $260.85M | $300.50M | $243.01M | $196.72M | $160.40M |
| R&D | $166.42M | $252.04M | $180.43M | $137.17M | $104.40M |
| SG&A | $41.02M | $48.45M | $62.58M | $59.54M | $56.00M |
| Operating Income | -$158.37M | -$238.45M | -$89.28M | -$128.94M | -$98.52M |
| Interest Expense | – | – | $1.30M | $2.40M | $2.60M |
| Tax Expense | -$93.00K | $2.36M | $18.19M | $2.50M | $0.00 |
| Net Income | -$191.09M | -$227.46M | -$106.79M | -$119.20M | -$105.54M |
| EPS (basic) | -22.4900 | -2.9600 | -1.7800 | -2.3500 | -2.2900 |
| EPS (diluted) | -22.4900 | -2.9600 | -1.7800 | -2.3500 | -2.2900 |
| Shares (diluted) | $8.50M | $76.83M | $60.16M | $50.74M | $46.12M |